Feb 05, 2016 15:38 pm UTC| Business
WASHINGTON, Feb. 5, 2016 -- What:Telephone/Web conference on U.S. Postal Service Fiscal Year 2016 First Quarter Results Who:Postmaster General and CEO Megan J. Brennan;CFO and Executive Vice President Joseph...
America’s Beauty Show 2016: A Big Bold Experience Filled With Glitz, Glamour, Pizzazz
Feb 05, 2016 15:12 pm UTC| Business
McCormick Place March 12, 13, 14 (Sat-Sun-Mon): Showcasing Hot, New Beauty Products Coming to "A Salon Near You" TO REQUEST MEDIA CREDENTIALS: [email protected] CHICAGO, Feb. 05, 2016 -- Thousands of salon...
Superior Uniform Group Declares Regular Quarterly Cash Dividend
Feb 05, 2016 15:00 pm UTC| Business
SEMINOLE, Fla., Feb. 05, 2016 -- The Board of Directors of Superior Uniform Group, Inc. (NASDAQ:SGC) today declared a quarterly dividend of $0.0825 per share, payable March 1, 2016, to shareholders of record February...
CoLucid Pharmaceuticals, Inc. (Nasdaq: CLCD) to Ring The Nasdaq Stock Market Closing Bell
Feb 05, 2016 15:00 pm UTC| Business
ADVISORY, Feb. 05, 2016 -- What:CoLucid Pharmaceuticals, Inc. (Nasdaq:CLCD), a Phase 3 clinical-stage biopharmaceutical company that is developing its lead product candidate, lasmiditan, for the acute treatment of...
Global Touchfree Intuitive Gesture Control Market Competition Forecast & Opportunities Report 2016
Feb 05, 2016 14:50 pm UTC| Business
Dublin, Feb. 05, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/9j6nf2/global_touchfree) has announced the addition of the "Global Touchfree Intuitive Gesture Control Market, By...
Holy Name Medical Center Enrolls first US Patient in Ground-Breaking Gene Therapy Clinical Trial
Feb 05, 2016 14:46 pm UTC| Business
TEANECK, N.J., Feb. 5, 2016 -- Holy Name Medical Center is the first hospital in the United States to participate in a groundbreaking clinical study, called STOP-PAD, which may help prevent patients from needing limb...
Coherus BioSciences to Present at Bloomberg Intelligence Healthcare Event on February 12th
Feb 05, 2016 14:30 pm UTC| Business
REDWOOD CITY, Calif., Feb. 05, 2016 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a leading pure-play, global biosimilars company with late-stage clinical products, today announced that Denny Lanfear, President and Chief...